![Intercell Outlicenses Group B Streptococcus Vaccine](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
![Intercell Outlicenses Group B Streptococcus Vaccine](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Intercell Outlicenses Group B Streptococcus Vaccine
Worldwide Biotech 2009, Feb 1, 21, 2
-
- 2,99 €
-
- 2,99 €
Beschreibung des Verlags
*- Group B Streptococcus vaccine program licensed to Novartis - Intellectual property cross license agreement will allow Novartis to focus on vaccines and Intercell on therapeutic antibodies in this indication* *- Extension of collaboration with Sanofi Pasteur on undisclosed bacterial vaccine towards product development*
Mehr ähnliche Bücher
Ablynx Selects a Novel Pre-Clinical Development Candidate for Administration VIA Pulmonary Delivery
2010
Fujitsu and Nagoya University Develop Technology Enabling High-Speed Detection of Toxic Proteins Using DNA Aptamers
2010
Biocurex Updates Its Shareholders
2011
ABLYNX RECEIVES EUR1.2 MILLION GRANT TO FURTHER ADVANCE ITS ANTI-IL-6R PROGRAMME, ALX-0061
2010
Enpublishing: CDC Software Acquires Computility, A Cloud-Based Saas Solution to be Added to Its CDC Gomembers Platform for the Not-for Profit Market
2010
Smart Chip System Used to Evaluate Homspera in Wound Healing Studies
2009
Mehr Bücher von Worldwide Biotech
Inhaler Devices Still a Major Hurdle in Asthma/Copd
2008
UCB Launches Cimplicity to Enhance Treatment Support for Cimzia
2008
Subjects Enrolled in Presept Colorectal Cancer Screening
2008
Is Cost Containment Impacting Pharmaceutical Innovation?
2008
Methylgene to Resume Development of MGCD0103 (Mocetinostat)
2009
Avita Gets AU$2M from US Military to Speed Device Approval
2009